In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d

Annals of Internal Medicine 2026

View at publisher
Authors: Tess E. Allan, L. Kristin Newby
DOI: 10.7326/annals-25-05115-jc
Cited by: 0
References: 1

Abstract

CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Diabetes Cardiovascular Risks and Lipoproteins Bioactive Compounds in Plants

Publication details

Journal / source
Annals of Internal Medicine
Volume
179
Issue
1
Pages
JC9–JC9
Publication date
1 January 2026
Language
EN